{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:24:17Z","timestamp":1787606657483,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00266-026-05872-6","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:32:13Z","timestamp":1779377533000},"page":"5415-5426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination Therapy in Androgenetic Alopecia: A Network Meta-Analysis of Minoxidil and Other Pharmacological Agents"],"prefix":"10.1007","volume":"50","author":[{"given":"Yanzhi","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BingShen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"4","key":"5872_CR1","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jaad.2021.08.067","volume":"89","author":"JL Gao","year":"2023","unstructured":"Gao JL, et al. Androgenetic alopecia in transgender and gender diverse populations: a review of therapeutics. J Am Acad Dermatol. 2023;89(4):774\u201383.","journal-title":"J Am Acad Dermatol"},{"issue":"2s","key":"5872_CR2","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.jaad.2023.05.004","volume":"89","author":"NY Ly","year":"2023","unstructured":"Ly NY, et al. Medical and procedural treatment of androgenetic alopecia-where are we? J Am Acad Dermatol. 2023;89(2s):S36-s39.","journal-title":"J Am Acad Dermatol"},{"key":"5872_CR3","doi-asserted-by":"publisher","first-page":"116022","DOI":"10.1016\/j.ejmech.2023.116022","volume":"264","author":"S Wu","year":"2024","unstructured":"Wu S, et al. Progress on the mechanism of natural products alleviating androgenetic alopecia. Eur J Med Chem. 2024;264:116022.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"5872_CR4","first-page":"15","volume":"149","author":"BM Piraccini","year":"2014","unstructured":"Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014;149(1):15\u201324.","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"5872_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","volume":"57","author":"F Lolli","year":"2017","unstructured":"Lolli F, et al. Androgenetic alopecia: a review. Endocrine. 2017;57(1):9\u201317.","journal-title":"Endocrine"},{"issue":"3","key":"5872_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4103\/ijdvl.IJDVL_262_17","volume":"84","author":"L Martinez-Jacobo","year":"2018","unstructured":"Martinez-Jacobo L, et al. Genetic and molecular aspects of androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2018;84(3):263\u20138.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"5872_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40257-019-00479-x","volume":"21","author":"M Starace","year":"2020","unstructured":"Starace M, et al. Female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol. 2020;21(1):69\u201384.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"5872_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/ijd.15378","volume":"60","author":"E Chovarda","year":"2021","unstructured":"Chovarda E, et al. The role of prostaglandins in androgenetic alopecia. Int J Dermatol. 2021;60(6):730\u20135.","journal-title":"Int J Dermatol"},{"issue":"22","key":"5872_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399402005112","volume":"4","author":"JA Ellis","year":"2002","unstructured":"Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4(22):1\u201311.","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"5872_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000508228","volume":"33","author":"JM V\u00f6lker","year":"2020","unstructured":"V\u00f6lker JM, et al. Caffeine and its pharmacological benefits in the management of androgenetic alopecia: a review. Skin Pharmacol Physiol. 2020;33(3):93\u2013109.","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"5872_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40257-022-00730-y","volume":"24","author":"D Saceda-Corralo","year":"2023","unstructured":"Saceda-Corralo D, et al. What\u2019s new in therapy for male androgenetic alopecia? Am J Clin Dermatol. 2023;24(1):15\u201324.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"5872_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1574884712666170310111125","volume":"12","author":"T Arif","year":"2017","unstructured":"Arif T, et al. Dutasteride in androgenetic alopecia: an update. Curr Clin Pharmacol. 2017;12(1):31\u20135.","journal-title":"Curr Clin Pharmacol"},{"issue":"4","key":"5872_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/14728214.2022.2149735","volume":"27","author":"HA Ram\u00edrez-Mar\u00edn","year":"2022","unstructured":"Ram\u00edrez-Mar\u00edn HA, Tosti A. Emerging drugs for the treatment of alopecia areata. Expert Opin Emerg Drugs. 2022;27(4):379\u201387.","journal-title":"Expert Opin Emerg Drugs"},{"key":"5872_CR14","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ et al. Revised Cochrane risk of bias tool for randomized trials (RoB 2.0). 2016. https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/archive-rob-2-0-2016."},{"issue":"5","key":"5872_CR15","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1524-4733.2008.00347.x","volume":"11","author":"JP Jansen","year":"2008","unstructured":"Jansen JP, et al. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. 2008;11(5):956\u201364.","journal-title":"Value Health"},{"issue":"1","key":"5872_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.29271\/jcpsp.2024.01.11","volume":"34","author":"G Afzal","year":"2024","unstructured":"Afzal G, et al. Efficacy of platelet-rich plasma versus 5% topical monixidil for the treatment of androgenetic alopecia. J Coll Physicians Surg Pak. 2024;34(1):11\u20135.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"4","key":"5872_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/DSS.0000000000000665","volume":"42","author":"R Alves","year":"2016","unstructured":"Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg. 2016;42(4):491\u20137.","journal-title":"Dermatol Surg"},{"issue":"2","key":"5872_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000079595","volume":"209","author":"E Arca","year":"2004","unstructured":"Arca E, et al. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology. 2004;209(2):117\u201325.","journal-title":"Dermatology"},{"issue":"9","key":"5872_CR19","first-page":"905","volume":"22","author":"M Asim","year":"2023","unstructured":"Asim M, et al. A randomized control trial comparing the efficacy of platelet-rich plasma and 5% topical minoxidil for the treatment of androgenetic alopecia. J Drugs Dermatol. 2023;22(9):905\u20139.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"5872_CR20","doi-asserted-by":"publisher","first-page":"2182618","DOI":"10.1080\/09546634.2023.2182618","volume":"34","author":"M Balasundaram","year":"2023","unstructured":"Balasundaram M, Kumari R, Ramassamy S. Efficacy of autologous Platelet-rich plasma therapy versus topical minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial. J Dermatol Treat. 2023;34(1):2182618.","journal-title":"J Dermatol Treat"},{"issue":"5","key":"5872_CR21","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00403-022-02512-2","volume":"315","author":"EA Bassiouny","year":"2023","unstructured":"Bassiouny EA, et al. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study. Arch Dermatol Res. 2023;315(5):1293\u2013304.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"5872_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/jocd.15979","volume":"23","author":"AS Bazargan","year":"2024","unstructured":"Bazargan AS, et al. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial. J Cosmet Dermatol. 2024;23(2):543\u201351.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"5872_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/ijt.ijt_72_22","volume":"15","author":"AV Bharadwaj","year":"2023","unstructured":"Bharadwaj AV, et al. Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: a pilot, randomized open-label study. Int J Trichol. 2023;15(2):56\u201362.","journal-title":"Int J Trichol"},{"issue":"10","key":"5872_CR24","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1111\/jocd.14788","volume":"21","author":"G Faghihi","year":"2022","unstructured":"Faghihi G, et al. Comparison between \u201c5% minoxidil plus 2% flutamide\u201d solution vs. \u201c5% minoxidil\u201d solution in the treatment of androgenetic alopecia. J Cosmet Dermatol. 2022;21(10):4447\u201353.","journal-title":"J Cosmet Dermatol"},{"key":"5872_CR25","doi-asserted-by":"publisher","first-page":"101124","DOI":"10.1016\/j.eclinm.2021.101124","volume":"40","author":"PR Feldman","year":"2021","unstructured":"Feldman PR, et al. Safety and efficacy of ALRV5XR in men with androgenetic alopecia: a randomised, double-blinded, placebo-controlled clinical trial. EClinicalMedicine. 2021;40:101124.","journal-title":"EClinicalMedicine"},{"key":"5872_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2024.07.260","volume":"5","author":"D Fernandes Melo","year":"2024","unstructured":"Fernandes Melo D, et al. Efficacy of botulinum toxin in male androgenetic alopecia: a triple-blind, randomized clinical trial. J Am Acad Dermatol. 2024;5:63.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5872_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/09546634.2019.1654070","volume":"32","author":"S Ghonemy","year":"2021","unstructured":"Ghonemy S, Alarawi A, Bessar H. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation. J Dermatol Treat. 2021;32(2):236\u201341.","journal-title":"J Dermatol Treat"},{"issue":"1","key":"5872_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/14764172.2017.1341046","volume":"20","author":"L Gong","year":"2018","unstructured":"Gong L, et al. The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: a randomized pilot study. J Cosmet Laser Ther. 2018;20(1):58\u201363.","journal-title":"J Cosmet Laser Ther"},{"issue":"15","key":"5872_CR29","doi-asserted-by":"publisher","first-page":"adv00247","DOI":"10.2340\/00015555-3609","volume":"100","author":"P Gressenberger","year":"2020","unstructured":"Gressenberger P, et al. Platelet-rich plasma for androgenetic alopecia treatment: a randomized placebo-controlled pilot study. Acta Dermato-Venereologica. 2020;100(15):adv00247.","journal-title":"Acta Dermato-Venereologica"},{"issue":"3","key":"5872_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaad.2013.10.049","volume":"70","author":"W Gubelin Harcha","year":"2014","unstructured":"Gubelin Harcha W, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014;70(3):489-498.e3.","journal-title":"J Am Acad Dermatol"},{"key":"5872_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.18433\/jpps31456","volume":"24","author":"D Hossein Mostafa","year":"2021","unstructured":"Hossein Mostafa D, et al. Efficacy of cetirizine 1% versus minoxidil 5% topical solution in the treatment of male alopecia: a randomized, single-blind controlled study. J Pharm Pharm Sci. 2021;24:191\u20139.","journal-title":"J Pharm Pharm Sci"},{"issue":"4","key":"5872_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/1346-8138.12422","volume":"41","author":"SJ Jo","year":"2014","unstructured":"Jo SJ, et al. Topical valproic acid increases the hair count in male patients with androgenetic alopecia: a randomized, comparative, clinical feasibility study using phototrichogram analysis. J Dermatol. 2014;41(4):285\u201391.","journal-title":"J Dermatol"},{"issue":"7","key":"5872_CR33","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/jdv.13324","volume":"30","author":"V Kanti","year":"2016","unstructured":"Kanti V, et al. Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial. J Eur Acad Dermatol Venereol JEADV. 2016;30(7):1183\u20139.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"3","key":"5872_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1067\/mjd.2002.124088","volume":"47","author":"EA Olsen","year":"2002","unstructured":"Olsen EA, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"5872_CR35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","volume":"57","author":"EA Olsen","year":"2007","unstructured":"Olsen EA, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57(5):767\u201374.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"5872_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/JCAS.JCAS_232_20","volume":"15","author":"S Pachar","year":"2022","unstructured":"Pachar S, et al. A comparative study of efficacy of 5% minoxidil and 5% minoxidil plus platelet-rich plasma in same patient for treatment of androgenetic alopecia. J Cutan Aesthet Surg. 2022;15(1):71\u20136.","journal-title":"J Cutan Aesthet Surg"},{"issue":"2","key":"5872_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/jdv.17738","volume":"36","author":"BM Piraccini","year":"2022","unstructured":"Piraccini BM, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36(2):286\u201394.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"5872_CR38","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/jocd.15953","volume":"23","author":"A Rossi","year":"2024","unstructured":"Rossi A, Caro G. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: a prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial. J Cosmet Dermatol. 2024;23(2):502\u20139.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"5872_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0378-6323.188652","volume":"83","author":"SJ Shanshanwal","year":"2017","unstructured":"Shanshanwal SJ, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded study. Indian J Dermatol Venereol Leprol. 2017;83(1):47\u201354.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"5872_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00128071-200708050-00003","volume":"8","author":"HS Shin","year":"2007","unstructured":"Shin HS, et al. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss-a randomized, double-blind, comparative clinical trial. Am J Clini Dermatol. 2007;8(5):285\u201390.","journal-title":"Am J Clini Dermatol"},{"issue":"12","key":"5872_CR41","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/jdv.15171","volume":"32","author":"P Suchonwanit","year":"2018","unstructured":"Suchonwanit P, et al. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol JEADV. 2018;32(12):2257\u201363.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"7","key":"5872_CR42","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/jocd.15825","volume":"22","author":"S Wu","year":"2023","unstructured":"Wu S, et al. Evaluation of platelet-rich plasma plus basic fibroblast growth factor combined with minoxidil in the treatment of androgenetic alopecia: a randomized controlled trial. J Cosmet Dermatol. 2023;22(7):1995\u20132002.","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"5872_CR43","doi-asserted-by":"publisher","first-page":"e15262","DOI":"10.1111\/dth.15262","volume":"35","author":"D Chen","year":"2022","unstructured":"Chen D, et al. Efficacy comparison of monotherapies and combination therapies for androgenetic alopecia: a Bayesian network meta-analysis. Dermatol Ther. 2022;35(3):e15262.","journal-title":"Dermatol Ther"},{"issue":"11","key":"5872_CR44","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1111\/jocd.15328","volume":"21","author":"AM Ammar","year":"2022","unstructured":"Ammar AM, et al. Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: a cross sectional-comparative study. J Cosmet Dermatol. 2022;21(11):5790\u20139.","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"5872_CR45","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1080\/09546634.2022.2109567","volume":"33","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Talukder M, Williams G. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. J Dermatolog Treat. 2022;33(7):2946\u201362.","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"5872_CR46","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","volume":"84","author":"M Randolph","year":"2021","unstructured":"Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737\u201346.","journal-title":"J Am Acad Dermatol"},{"key":"5872_CR47","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2147\/CCID.S385861","volume":"16","author":"M Kaiser","year":"2023","unstructured":"Kaiser M, et al. Treatment of androgenetic alopecia: current guidance and unmet needs. Clin Cosmet Investig Dermatol. 2023;16:1387\u2013406.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"5872_CR48","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdin.2023.07.005","volume":"13","author":"S Ntshingila","year":"2023","unstructured":"Ntshingila S, et al. Androgenetic alopecia: an update. JAAD Int. 2023;13:150\u20138.","journal-title":"JAAD Int"},{"key":"5872_CR49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2147\/CCID.S398950","volume":"16","author":"C Wang","year":"2023","unstructured":"Wang C, et al. The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review. Clin Cosmet Investig Dermatol. 2023;16:603\u201312.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"5872_CR50","first-page":"678","volume":"28","author":"M Sovak","year":"2002","unstructured":"Sovak M, et al. Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience. Dermatol Surg. 2002;28(8):678\u201385.","journal-title":"Dermatol Surg"},{"issue":"1","key":"5872_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5414\/CP202467","volume":"54","author":"M Caserini","year":"2016","unstructured":"Caserini M, et al. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. Int J Clin Pharmacol Ther. 2016;54(1):19\u201327.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"5872_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/dth.12246","volume":"28","author":"R Hu","year":"2015","unstructured":"Hu R, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28(5):303\u20138.","journal-title":"Dermatol Ther"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-05872-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-026-05872-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-05872-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:02:07Z","timestamp":1787605327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-026-05872-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":52,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5872"],"URL":"https:\/\/doi.org\/10.1007\/s00266-026-05872-6","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Human and Animal Rights, or Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study informed consent is not required","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}